RDY
Dr. Reddy’s Laboratories Ltd ADRNYSE
Healthcare • Drug Manufacturers - Specialty & Generic
Updated 1 day ago
Coverage limited
Factor tilt: Quality-tilted Large Cap
$12.77-0.39%
Close Oct 13, 2026
- Market cap
- $10.63B
- 1 month
- +7.2%
- 3 months
- 0.0%
- 1 year
- -10.9%
- 52-week range
- $11.38$15.38
- Dividend, last 12 mo
- $0.0834 · 0.65% yield
- Last ex-date
- Jul 24, 2026 · $0.0834
- Short interest
- 28.4M sharessettled Sep 30, 2026 · -2.0% since Sep 15, 2026 · FINRA
End-of-day close from stored market data, not a live quote.
Portfolio context
Sign in to see your position size
We’ll show you if RDY is in your portfolio and how much it contributes.
Sign inMarket context
Loading market dates
No upcoming ex-dividend date announced
No 8-K filings in the last 30 days.
Smart money context
Holder IQ: MEDIUM
41 top institutions tracked
as of 2026-Q2 (filed 2026-09-23)
Last 13F trend: accumulating (heavy)
Unlock crowding heatmapUnlock filer discoveryInsider context
Sentiment: unknown
No recent insider trades detected.
Red flags: 0
Largest 13-F holders · Q2 2026
239 filers reported a long position in RDY for Q2 2026. 13-F holdings are filed up to 45 days after the quarter ends.
| Holder | Value | Shares | Shares vs Q1 2026 |
|---|---|---|---|
| Robeco Institutional Asset Management B.V. | $261.1M | 18M | +4.9% |
| MORGAN STANLEY | $158.5M | 10.9M | +16.7% |
| BlackRock, Inc. | $153.4M | 10.6M | -8.6% |
| ROYAL BANK OF CANADA | $133.5M | 9.2M | -7.7% |
| Aikya Investment Management Ltd | $123.1M | 8.5M | +6.2% |
| RENAISSANCE TECHNOLOGIES LLC | $106.5M | 7.3M | -6.5% |
| DIMENSIONAL FUND ADVISORS LP | $77M | 5.3M | -0.2% |
| JPMORGAN CHASE & CO | $60.5M | 4.1M | -6.9% |
| STATE STREET CORP | $59.8M | 4.1M | +2.4% |
| ALLIANCEBERNSTEIN L.P. | $51.7M | 3.7M | +46.8% |
Get the Full Analysis for RDY
Unlock detailed insider transactions, institutional holder changes, factor exposures, and personalized alerts. Start free with your own portfolio.